ATE206915T1 - Behandlung von angstzuständen - Google Patents
Behandlung von angstzuständenInfo
- Publication number
- ATE206915T1 ATE206915T1 AT95930169T AT95930169T ATE206915T1 AT E206915 T1 ATE206915 T1 AT E206915T1 AT 95930169 T AT95930169 T AT 95930169T AT 95930169 T AT95930169 T AT 95930169T AT E206915 T1 ATE206915 T1 AT E206915T1
- Authority
- AT
- Austria
- Prior art keywords
- anxiety
- treatment
- agonist
- acts
- provides
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title abstract 2
- 230000036506 anxiety Effects 0.000 title abstract 2
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 abstract 1
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/30—Unsaturated compounds
- C07C62/38—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Materials For Photolithography (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28995794A | 1994-08-12 | 1994-08-12 | |
| US33734994A | 1994-11-10 | 1994-11-10 | |
| US49671095A | 1995-06-29 | 1995-06-29 | |
| PCT/US1995/010318 WO1996004901A1 (en) | 1994-08-12 | 1995-08-14 | Composition and method for treating anxiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE206915T1 true ATE206915T1 (de) | 2001-11-15 |
Family
ID=27403950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95930169T ATE206915T1 (de) | 1994-08-12 | 1995-08-14 | Behandlung von angstzuständen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5882671A (de) |
| EP (1) | EP0776201B1 (de) |
| JP (1) | JP3614435B2 (de) |
| AT (1) | ATE206915T1 (de) |
| AU (1) | AU3364995A (de) |
| CA (1) | CA2195782A1 (de) |
| DE (1) | DE69523324T2 (de) |
| DK (1) | DK0776201T3 (de) |
| ES (1) | ES2162936T3 (de) |
| PT (1) | PT776201E (de) |
| WO (1) | WO1996004901A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA969485B (en) * | 1995-11-16 | 1998-05-12 | Lilly Co Eli | Excitatory amino acid receptor antagonists. |
| US5688826A (en) * | 1995-11-16 | 1997-11-18 | Eli Lilly And Company | Excitatory amino acid derivatives |
| GB9605429D0 (en) * | 1995-11-16 | 1996-05-15 | Lilly Co Eli | Excitatory amino acid receptor antagonists |
| US5912248A (en) * | 1995-11-16 | 1999-06-15 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| BR9611521A (pt) * | 1995-11-16 | 1999-06-29 | Lilly Co Eli | Antagonistas de receptor de aminoácido excitador |
| CN1202167A (zh) * | 1995-11-16 | 1998-12-16 | 伊莱利利公司 | 兴奋性的氨基酸衍生物 |
| JP2001511131A (ja) * | 1997-01-29 | 2001-08-07 | イーライ・リリー・アンド・カンパニー | 月経前不快障害の処置 |
| ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| US6982361B1 (en) * | 2000-02-25 | 2006-01-03 | The Regents Of The University Of California | Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal |
| NZ526050A (en) * | 2001-01-11 | 2005-03-24 | Lilly Co Eli | Prodrugs of excitatory amino acids |
| US7038077B2 (en) * | 2001-01-11 | 2006-05-02 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| US7456221B2 (en) * | 2001-12-21 | 2008-11-25 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| US20040116489A1 (en) * | 2002-02-12 | 2004-06-17 | Massey Steven Marc | Synthetic excitatory amino acids |
| US20050192273A1 (en) * | 2002-04-03 | 2005-09-01 | Johnson Bryan G. | Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
| KR20200035035A (ko) | 2017-07-31 | 2020-04-01 | 노파르티스 아게 | 코카인 사용 감소 또는 코카인 사용 재발 예방에 있어서 마보글루란트의 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9325368D0 (en) * | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
| US5750566A (en) * | 1994-08-12 | 1998-05-12 | Eli Lilly And Company | Synthetic excitatory amino acids |
-
1995
- 1995-08-14 EP EP95930169A patent/EP0776201B1/de not_active Expired - Lifetime
- 1995-08-14 ES ES95930169T patent/ES2162936T3/es not_active Expired - Lifetime
- 1995-08-14 DE DE69523324T patent/DE69523324T2/de not_active Expired - Fee Related
- 1995-08-14 AU AU33649/95A patent/AU3364995A/en not_active Abandoned
- 1995-08-14 AT AT95930169T patent/ATE206915T1/de not_active IP Right Cessation
- 1995-08-14 PT PT95930169T patent/PT776201E/pt unknown
- 1995-08-14 JP JP50756496A patent/JP3614435B2/ja not_active Expired - Fee Related
- 1995-08-14 DK DK95930169T patent/DK0776201T3/da active
- 1995-08-14 WO PCT/US1995/010318 patent/WO1996004901A1/en not_active Ceased
- 1995-08-14 CA CA002195782A patent/CA2195782A1/en not_active Abandoned
-
1997
- 1997-01-21 US US08/786,170 patent/US5882671A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69523324D1 (de) | 2001-11-22 |
| HK1013958A1 (en) | 1999-09-17 |
| CA2195782A1 (en) | 1996-02-22 |
| DK0776201T3 (da) | 2001-11-26 |
| DE69523324T2 (de) | 2002-07-04 |
| PT776201E (pt) | 2002-03-28 |
| AU3364995A (en) | 1996-03-07 |
| US5882671A (en) | 1999-03-16 |
| EP0776201B1 (de) | 2001-10-17 |
| EP0776201A4 (de) | 1999-07-07 |
| JPH11507008A (ja) | 1999-06-22 |
| EP0776201A1 (de) | 1997-06-04 |
| JP3614435B2 (ja) | 2005-01-26 |
| ES2162936T3 (es) | 2002-01-16 |
| WO1996004901A1 (en) | 1996-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE206915T1 (de) | Behandlung von angstzuständen | |
| DE69616375D1 (de) | Nicht-allosterische GABA A Agonisten zur Behandlung von Schlafstörungen | |
| DE69732868D1 (de) | Mittel gegen Juckreiz | |
| DE69815090D1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| DE69737402D1 (de) | Vorrichtung zur Behandlung von neurodegenerativen Störungen | |
| DE69726724D1 (de) | Tetrahydropteridine und pyridylpiperazine zur behandlung von neurologischen störungen | |
| ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
| PT841928E (pt) | Formulacao de libertacao prolongada de d-trep-metilfenidato | |
| NO20020837L (no) | Fremgangsmåte for å identifisere et stoffs egenskaper hensyn til humane prostaglandin D-reseptorer | |
| EA200000349A1 (ru) | Способ лечения оппозиционного расстройства | |
| ATE256671T1 (de) | 2-phenyl-substituierte 1-(n-phenylaminoalkyl)- piperazin-derivate | |
| NO944578L (no) | Eksitatoriske aminosyre reseptor antagonister | |
| DE69635708D1 (de) | Tetrandrin zur behandlung von augenentzündungen | |
| ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
| ATE303362T1 (de) | Chalcon-derivate mit antiproliferativer aktivität | |
| ATE320832T1 (de) | Behandlung von haarfollikeln mit neurokinin 1 rezeptor antagonisten | |
| BG102064A (en) | Method for increasing the retinal blood circulation | |
| DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| DE69736180D1 (de) | Behandlung von manischen erkrankungen | |
| DE69731658D1 (de) | Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen | |
| ATE202552T1 (de) | Benzamide für behandlung von neurodegenerativen störungen | |
| DE69731657D1 (de) | Die verwendung von nk-1 rezeptor antagonisten für die behandlung von substanz-verwendung störungen | |
| ES2180643T3 (es) | Procedimiento para tratar la disfuncion cognitiva. | |
| PT950056E (pt) | N-(piridinilamino) isoindolinas e compostos relacionados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |